IRIS
CORTI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 880
NA - Nord America 715
AS - Asia 84
OC - Oceania 1
SA - Sud America 1
Totale 1.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 715
SE - Svezia 670
IT - Italia 58
FI - Finlandia 54
DE - Germania 45
IE - Irlanda 38
IN - India 32
CN - Cina 25
SG - Singapore 18
GB - Regno Unito 5
IR - Iran 5
NL - Olanda 5
JP - Giappone 3
RO - Romania 2
AU - Australia 1
CL - Cile 1
IQ - Iraq 1
NO - Norvegia 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 1.681
Salva come PNG Salva come JPEG
Città #
Lawrence 266
Princeton 266
Helsinki 54
Ashburn 45
Dublin 38
New York 32
Pune 32
Milan 30
Shanghai 22
Los Angeles 10
Seattle 9
Washington 5
Borås 4
San Diego 4
Ancona 3
Brescia 3
London 3
Rome 3
Singapore 3
Maropati 2
Naaldwijk 2
Teverola 2
Tokyo 2
Zanjan 2
Arbil 1
Arnsberg 1
Bergen 1
Böblingen 1
Chiaravalle 1
Falconara Marittima 1
Ferrara 1
Genoa 1
Gunzenhausen 1
Hanover 1
Henderson 1
Honolulu 1
Karasawa 1
Kashan 1
Kish 1
Kortenhoef 1
Missaglia 1
Mountain View 1
Newcastle 1
Osimo 1
Rockville 1
Sacramento 1
San Mateo 1
Santiago 1
Spalding 1
Tehran 1
Temecula 1
Torino 1
Woodbridge 1
Totale 871
Salva come PNG Salva come JPEG
Nome #
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 20
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 20
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 17
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 17
Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA(1-64)) in the rat heart 15
Aminopeptidase N (CD13)-positive bone marrow-derived cells induce angiogenesis and tumor growth: A potential non-malignant immune cell target against cancer 15
Anti-urokinase monoclonal antibody, matrix bearing it, test method, biochemical test kits which use it. 15
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 15
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 15
Breaching the blood–brain tumor barrier for tumor therapy 15
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 15
Altered Chromogranin A Circulating Levels in Meniere’s Disease 14
Chromogranin-A production and fragmentation in patients with Takayasu arteritis. 14
Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improved insulin sensitivity 14
Ways to improve tumor uptake and penetration of drugs into solid tumors 13
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 13
Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting 13
Chromogranin A plasma levels predict mortality in COVID-19 12
Isoaspartate-glycine-arginine: A new tumor vasculature-targeting motif 12
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype 12
Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer 11
A receptor-antibody sandwich assay for teicoplanin. 11
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours 11
[Activation and role of the tumor necrosis factor-alpha in congestive heart failure]. FT Attivazione e ruolo del fattore di necrosi tumorale alfa nello scompenso cardiaco congestizio. 11
Anti-idiotype monoclonal antibody directed against anti-TNF antibodies 11
Won't you come on in? How to favor lymphocyte infiltration in tumors 11
T cells redirected to a minor histocompatibility antigen instruct intratumoral TNFα expression and empower adoptive cell therapy for solid tumors 11
A new chromogranin A-dependent angiogenic switch activated by thrombin 11
Spatiotemporal regulation of tumor angiogenesis by circulating chromogranin a cleavage and neuropilin-1 engagement 11
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity 11
Commentary: Granins, Secretory Granule Biogenesis, and Transport 10
Vascular attack and immunotherapy: a 'two hits' approach to improve biological treatment of cancer 10
Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications, and alternative roads 10
Liposome-Mediated Therapy of Neuroblastoma 10
Agents regulating vascular permeability 10
Immobilized oligopeptides 10
Solid-phase receptor assay for antibiotics of the vancomycin class. 10
Process for identifying polynucleotide sequences and device suitable therefor 10
Autocrine saturation of pro-urokinase receptors on human A431cells 10
Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion 10
A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator. 10
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 9
Nitric oxide synthase in CHF - Reply 9
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy 9
Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium? 9
Conversation galante: How the immune and the neuroendocrine systems talk to each other 9
Oxidative stress biomarkers and chromogranin A in uremic patients: Effects of dialytic treatment 9
Tumor necrosis factor in heart failure 9
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein 9
Monoclonal antibodies against the TNF type-I receptor, process for their production and use thereofAnticorpi monoclonali anti-recettore di tipo 1 del TNF alfa, procedimento per la loro produzione e loro uso 9
Fusion of cytokines and targeting peptides 9
Receptor-antibody sandwich assay. 9
Circulating chromogranin A 9
Cromogranina A per uso come reagente in un metodo diagnostico o prognostico 9
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging 9
Tumor necrosis factor-α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the successful treatment of patients with infliximab 9
Vasostatins 9
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to αvβ3 without Promoting Integrin Allosteric Activation 9
Affinity enhancement of complementary peptide recognition 9
Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells. 9
A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins 9
Antigenic regions of human chromogranin A and their topographic relationships with structural functional domains 8
Oral direct thrombin inhibition: a double-edged sword? 8
STRUCTURAL BASIS FOR THE INTERATION OF ISODGR WITH RGD-BINDING SITE OF αvβ3 INTEGRIN 8
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. 8
Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression 8
NGR-Tagged Nano-Gold: a new CD13-selective carrier for cytokine delivery to tumors 8
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 8
Binding of the glycopeptide antibiotic teicoplanin to D-alanyl-D-alanine-agarose: the effect of micellar aggregates. 8
Functional expression of two soluble forms of the TNF-receptor type I in mammalian cells 8
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 8
Cytokine conjugates (IL-12 –peptide conjugates) 8
Modified cytokines for therapeutic use 8
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 8
Targeted delivery of IFN gamma to tumor vessels uncouples antitumor from counterregulatory mechanisms 8
High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment 8
Quantification of Chromogranin A and Its Fragments in Biological Fluids 7
Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching 7
Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy 7
Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action 7
Tumor-necrosis-factor soluble receptors in patients with various degrees of congestive-heart-failure 7
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas 7
Targeted drug delivery and penetration into solid tumors. 7
Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse 7
Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha 7
Synthesis and characterization of D-alanyl-D-alanine-agarose: a new bioselective adsorbent for affinity chromatography of glycopeptide antibiotics 7
Full-length human Chromogranin-A cardioactivity: myocardial, coronary and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts 7
Peptide-mediated Targeting of Cytokines to Tumor Vasculature: the NGR-hTNF Example 7
Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A 7
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. 7
Immunoconjugates for treatment of tumors 7
Process for the identification of proteolytic activity and / or inhibitors thereof 7
Tumor Necrosis Factor: methods and protocols 7
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 7
Regulation of tumor growth by circulating full-length chromogranin A 7
Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study 7
Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion 7
TUMOUR NECROSIS FACTOR-ALPHA AS A MASTER REGULATOR OF INFLAMMATION IN ERDHEIM-CHESTER DISEASE: RATIONALE FOR THE SUCCESSFUL TREATMENT OF TWO PATIENTS WITH INFLIXIMAB 7
Spontaneous formation of L-isoaspartate and gain of function in fibronectin 7
Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers 7
Totale 984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 9 1 1 0 0 0 0 0 1 3 1 0
2020/20215 0 0 0 1 0 0 4 0 0 0 0 0
2021/2022111 0 0 0 70 0 7 7 5 2 2 1 17
2022/20231.296 604 245 115 3 2 138 42 67 64 5 5 6
2023/2024298 5 8 62 36 26 88 24 33 0 16 0 0
Totale 1.791